Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma
- 1 January 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Computer Assisted Tomography
- Vol. 34 (1), 127-134
- https://doi.org/10.1097/rct.0b013e3181b1587a
Abstract
We compared the diagnostic performance of ferucarbotran-enhanced magnetic resonance imaging (MRI) with that of gadoxetic acid-enhanced MRI for the preoperative detection of hepatocellular carcinoma (HCC) of 27 consecutive patients (male-female, 21:6; 33-76 years) with 38 surgically proven HCCs (mean diameter, 2.8 cm; range, 0.8-10.2 cm) on a 3.0-T unit. Three observers independently reviewed each MR image in a random order on a tumor-by-tumor basis. The diagnostic accuracy of these techniques for the detection of HCC, sensitivity, positive and negative predictive values was evaluated. For each observer, the values of the area under the receiver operating characteristic curve (Az) were 1.000, 1.000, and 0.974 for ferucarbotran-enhanced MRI and 1.000, 0.987, and 1.000 for gadoxetic acid-enhanced MRI, and the differences were not statistically significant between 2 techniques for each observer (P > 0.05). For each observer, sensitivities were 100%, 100%, and 92.1% for ferucarbotran-enhanced MRI and 100%, 94.7%, and 100% for gadoxetic acid-enhanced MRI with no statistical significance (P > 0.005). The differences of the positive and negative predictive values of 2 techniques for each observer were not statistically significant (P > 0.05). Ferucarbotran-enhanced MRI and gadoxetic acid-enhanced MRI show a similar diagnostic performance for the preoperative detection of HCCs.Keywords
This publication has 30 references indexed in Scilit:
- Ferucarbotran-Enhanced 3.0-T Magnetic Resonance Imaging Using Parallel Imaging Technique Compared With Triple-Phase Multidetector Row Computed Tomography for the Preoperative Detection of Hepatocellular CarcinomaJournal of Computer Assisted Tomography, 2008
- Superparamagnetic Iron Oxide-Enhanced Liver Magnetic Resonance ImagingInvestigative Radiology, 2006
- Comparison of Superparamagnetic Iron Oxide–Enhanced and Gadobenate Dimeglumine–Enhanced Dynamic MRI for Detection of Small Hepatocellular CarcinomasAmerican Journal of Roentgenology, 2004
- Hepatocellular Carcinoma: Detection with Gadolinium- and Ferumoxides-enhanced MR Imaging of the LiverRadiology, 2002
- Contrast Agents for MR Imaging of the LiverRadiology, 2001
- Abdominal MR: liver and pancreasEuropean Radiology, 1999
- Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.American Journal of Roentgenology, 1999
- Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.Radiology, 1996
- Magnetic Resonance Imaging of the LiverTopics in Magnetic Resonance Imaging, 1995
- Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.Radiology, 1987